The new site will feature WuXi Biologics' recently launched microbial expression platform EffiX TM for the development and manufacturing of biologics with high yield, consistent quality ...

CHENGDU, China, June 9, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), today announced that it has kicked ...

BEIJING (Reuters) - WuXi Biologics said in a statement on Tuesday on WeChat that two of its subsidiaries being put on the U.S. Commerce Department's "unverified list" will have no impact on its ...

WuXi Biologics slid after its chairman trimmed his stake for a second time in four months. China Unicom rallied 8.5 per cent to HK$4.85, pacing gainers among blue chips on the benchmark Hang Seng ...

WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People ...

WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Wuxi Biologics (Cayman) Inc. + Watchlist Alert WXIBF US Closed Last Updated: Jun 17, 2025 11:05 a.m. EDT Delayed quote $ 3.2500 0.0400 1.25% Previous Close $3.2100 Toggle Chart Options Advanced ...

Get the annual and quarterly balance sheet of WuXi Biologics (Cayman) Inc. (WXIBF) including details of assets, liabilities and shareholders' equity.